Find trials
Search tips

Investigating the Feasibility and Clinical Utility of the Marpe Skin Scanner

Overview

About this study

The purpose of Part A of this study is to establish the feasibility of performing Marpé full body skin imaging at Mayo Clinic. The purpose of Part B of this study is to get a preliminary sense of the clinical utility of the approach.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 1. Patient scheduled for Canfield scanning, e.g., in the DER 3D CLINIC or another clinic.
  • 2. Patient ≥ 18 years of age.
  • 3. One of the following:
    • First-degree relative with melanoma (parent, sibling, child); OR
    • Personal history of cutaneous melanoma; OR
    • History of atypical nevi.

Exclusion Criteria:

  1. Patients with mobility issues.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 8/10/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Alexander Meves, M.D., M.B.A.

Open for enrollment

Contact information:

Cortney Kokkeler

(507) 266-0464

Kokkeler.Cortney@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20563844

Mayo Clinic Footer